(-)-Epigallocatechin-3-gallate induces apoptosis in human endometrial adenocarcinoma cells via ROS generation and p38 MAP kinase activation

Journal of Nutritional Biochemistry

Volumn 24, Issue 6, 2013, Pages 940-947

  Manohar, Murli ^a   Fatima, Iram ^a   Saxena, Ruchi ^a   Chandra, Vishal ^a   Sankhwar, Pushp L ^b   Dwivedi, Anila ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

( ) Epigallocatechin 3 gallate; Apoptosis; Endometrial cancer; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; CYCLIN D1; CYCLINE; EPIGALLOCATECHIN GALLATE; ESTROGEN RECEPTOR ALPHA; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROGESTERONE RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL PROLIFERATION; CELL VIABILITY; DISEASE MARKER; DOWN REGULATION; ENDOMETRIUM CARCINOMA; ENZYME ACTIVATION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PROTEIN EXPRESSION; UPREGULATION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES;

EID: 84878012866     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.06.013     Document Type: Article

References (39)

1. Gupta S., Hussain T., Mukhtar H. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 2003, 410:177-185.
2. Lu Y.P., Lou Y.R., Xie J.G., Peng Q.Y., Liao J., Yang C.S., et al. Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc Natl Acad Sci USA 2002, 99:12455-12460.
3. Witschi H., Espiritu I., Ly M., Uyeminami D., Morin D., Raabe O.G. Chemoprevention of tobacco smoke-induced lung tumors by inhalation of an epigallocatechin gallate (EGCG) aerosol: a pilot study. Inhal Toxicol 2004, 16:763-770.
4. Beltz L.A., Bayer D.K., Moss A.L., Simet I.M. Mechanisms of cancer prevention by green and black tea polyphenols. Anticancer Agents Med Chem 2006, 6:389-396.
5. Khan N., Afaq F., Saleem M., Ahmad N., Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 2006, 66:2500-2505.
6. Laschke M.W., Schwender C., Scheuer C., Vollmar B., Menger M.D. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Hum Reprod 2008, 23(10):2308-2318.
7. Zhang D., Al-Hendy M., Richard-Davis G., Montgomery-Rice V., Sharan C., Rajaratnam V., et al. Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice. Am J Obstet Gynecol 2010, 202(3):289.e1-289.e9.
8. Zhang D., Al-Hendy M., Richard-Davis G., Montgomery-Rice V., Rajaratnam V., Al-Hendy A. Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells. Fertil Steril 2010, 5:1887-1893.
9. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics. CA Cancer J Clin 2008, 58:71-96.
10. American Cancer Society. Estimated new cancer cases and deaths by sex, US, 2009. Available at documents/document/500809webpdf.pdf, page 4, accessed September 7, 2010. http://www.cancer.org/acs/groups/content/atnho/.
11. Lian Z., Niwa K., Tagami K., Hashimoto M., Gao J., Yokoyama Y., et al. Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice. Jpn J Cancer Res 2001, 92(7):726-734.
12. Lian Z., Niwa K., Gao J., Tagami K., Onczi K., Mori H., et al. Soybean isoflavones inhibit estrogen-stimulated gene expression in mouse uteri. Eur J Gynaecol Oncol 2004, 25(3):311-314.
13. Dann J.M., Sykes P.H., Mason D.R. Regulation of vascular endothelial growth factor in endometrial tumour cells by resveratrol and EGCG. Gynecol Oncol 2009, 113(3):374-378.
14. Fatima I., Chandra V., Saxena R., Manohar M., Sanghani Y., Hajela K., et al. 2,3-Diaryl-2H-1-benzopyran derivatives interfere with classical and non-classical estrogen receptor signaling pathways, inhibit Akt activation and induce apoptosis in human endometrial cancer cells. Mol Cell Endocrinol 2012, 348(1):198-210. 22.
15. Jos A., Camean A.M., Pflugmacher S., Segner H. The antioxidant glutathione in the fish cell lines EPC and BCF-2: response to model pro-oxidants as measured by three different fluorescent dyes. Toxicol In Vitro 2009, 23:546-553.
16. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
17. Delneste Y., Jeannin P., Potier L., Romero P., Bonnefoy J.Y. N-acetyl-l-cysteine exhibits antitumoral activity by increasing tumor necrosis factor alpha-dependent T-cell cytotoxicity. Blood 1997, 90(3):1124-1132.
18. Heyninck K., Denecker G., De Valck D., Fiers W., Beyaert R. Inhibition of tumor necrosis factor-induced necrotic cell death by the zinc finger protein A20. Anticancer Res 1999, 19(4B):2863-2868.
19. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p-38 protein kinases. Science 2002, 298:1911-1912.
20. Sartippour M.R., Heber D., Ma J., et al. Green tea and its catechins inhibit breast cancer xenografts. Nutr Cancer 2001, 40:149-156.
21. Masuda M., Suzui M., Weinstein I.B. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 2001, 7(12):4220-4229.
22. Kim M., Murakami A., Kawabata K., Ohigashi H. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells. Carcinogenesis 2005, 26(9):1553-1562.
23. Hou Z., Sang S., You H., Lee M.J., Hong J., Chin K.V., et al. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res 2005, 65(17).
24. Sexton E., Van Themsche C., LeBlanc K., Parent S., Lemoine P., Asselin E. Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells. Mol Cancer 2006, 17(5):45.
25. Simbula G., Columbano A., Ledda-Columbano G., Sanna L., Deidda M., Diana A., et al. Increased ROS generation and p53 activation in α-lipoic acid-induced apoptosis of hepatoma cells. Apoptosis 2007, 12:113-123.
26. Jaganathan S.K., Mandal M. Involvement of non-protein thiols, mitochondrial dysfunction, reactive oxygen species and p53 in honey-induced apoptosis. Invest New Drugs 2010, 28(5):624-633.
27. Shi X., Ye J., Leonard S.S., Ding M., Vallyathan V., Castranova V., et al. Antioxidant properties of (-)-epicatechin-3-gallate and its inhibition of Cr (VI)-induced DNA damage and Cr (IV)- or TPA-stimulated NF-kappaB activation. Mol Cell Biochem 2000, 206(1-2):125-132.
28. Azam S., Hadi N., Khan N.U., Hadi S.M. Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties. Toxicol In Vitro 2007, 18:555-561.
29. Zu K., Hawthorn L., Ip C. Up-regulation of c-Jun-NH2-kinase pathway contributes to the induction of mitochondria-mediated apoptosis by alphatocopheryl succinate in human prostate cancer cells. Mol Cancer Ther 2005, 4:43-50.
30. Iwamaru A., Iwado E., Kondo S., Newman R.A., Vera B., Rodriguez A.D., et al. Eupalmerin acetate, a novel anticancer agent from Caribbean gorgonianoctocorals, induces apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway. Mol Cancer Ther 2007, 6:184-192.
31. Cotgreave I.A. N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv Pharmacol 1997, 38:205-207.
32. Wang C.T., Chang H.H., Hsiao C.H., et al. The effects of green tea ( - )-epigallocatechin-3-gallate on reactive oxygen species in 3T3-L1preadipocyt es and adipocytes depend on the glutathione and 67 kDa laminin receptor pathways. Mol Nutr Food Res 2009, 53:349-360.
33. Leopold J.S.S. Development of anticancer drugs targeting the MAP kinase pathway. Oncogene 2000, 19:6594-6599.
34. Lau S.T., Lin Z.X., Leung P.S. Role of reactive oxygen species in brucein D-mediated p38-mitogen-activated protein kinase and nuclear factor-kappaB signalling pathways in human pancreatic adenocarcinoma cells. Br J Cancer 2010, 102(3):583-593.
35. Xia Z.G., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p3 8 MAP kinases on apoptosis. Science 1995, 270:1326-1331.
36. Konishi H.T., Fujiyoshi Y., Fukui H., Matsuzaki T., Yamamoto Y., Ono M., et al. Activation of protein kinase induced by H(2)O(2) and heat shock through distinct mechanisms dependent and independent of phosphatidyl-inositol 3-kinase. J Biochem 1999, 126:1136-1143.
37. Wang X., McCullough K.D., Franke T.F., Holbrook N.J. Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J Biol Chem 2000, 275:14624-14631.
38. Hyun M.S., Hur J.M., Mun Y.J., Kim D., Woo W.H. BBR induces apoptosis in HepG2 cell through an Akt-ASK1-ROS-p38MAPKs-linked cascade. J Cell Biochem 2010, 109:329-338.
39. Saeki K., Kobayashi N., Inazawa Y., Zhang H., Nishitoh H., Ichijo H., et al. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis. Biochem J 2002, 368:705-720.